Name | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
Symbol | HIF1A |
Aliases | MOP1; HIF-1ALPHA; HIF1-ALPHA |
Gene Product | - hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
Category | - Amplification in Prostate cancer
|
UniGene | Hs.197540 |
OMIM | 603348 |
Locus | 3091 |
Summary | Basic helix-loop-helix transcription factor; mediates transcriptional responses to hypoxia and dioxin-signaling; contains a PAS domain |
Gene Ontology | |
Expression | EST (428 ESTs, 191 libraries) |
Tissue ? |
Frequency ? |
Count ? |
adipose (1/10) | | 1/2445 |
adrenal gland (4/15) | | 5/17521 |
blood (2/27) | | 4/40686 |
bone (6/13) | | 18/26211 |
bone marrow (4/263) | | 5/38555 |
brain (14/204) | | 26/362011 |
cartilage (1/5) | | 1/11018 |
cervix (2/7) | | 2/28115 |
colon (7/853) | | 16/165626 |
ear (1/2) | | 1/12660 |
embryo (2/19) | | 10/37976 |
esophagus (1/6) | | 1/3022 |
eye (1/33) | | 5/93836 |
foreskin (1/4) | | 1/20040 |
head and neck (14/990) | | 18/79796 |
heart (1/22) | | 1/55494 |
intestine (1/4) | | 2/11528 |
kidney (9/86) | | 15/132968 |
liver (1/38) | | 3/46472 |
lung (11/312) | | 30/245386 |
muscle (4/21) | | 9/71297 |
nervous (4/475) | | 11/43438 |
oral cavity (1/18) | | 5/44567 |
ovary (3/144) | | 6/81880 |
pancreas (7/33) | | 22/117255 |
placenta (6/342) | | 14/157762 |
prostate (3/291) | | 9/109871 |
skin (4/31) | | 14/100815 |
spleen (1/7) | | 1/9511 |
stomach (12/312) | | 24/129930 |
testis (5/171) | | 14/117531 |
thyroid (1/24) | | 1/6853 |
umbilical cord (1/3) | | 2/6185 |
uncharacterized tissue (41/1773) | | 102/713325 |
uterus (9/212) | | 22/155110 |
|
SAGE (19913707 tags, 371 libraries) |
Tissue ? |
Frequency ? |
Count ? |
blood (1/1) | | 29/485230 |
brain (19/19) | | 133/4725782 |
cerebellum (1/1) | | 8/205120 |
colon (7/8) | | 19/1057210 |
eye (5/6) | | 34/1746596 |
foreskin (1/2) | | 1/9759 |
heart (1/1) | | 4/337428 |
kidney (2/2) | | 9/253883 |
liver (1/1) | | 5/200583 |
lung (1/1) | | 10/534858 |
mammary gland (17/19) | | 92/2509914 |
ovary (8/10) | | 63/1206235 |
pancreas (7/8) | | 25/657145 |
prostate (12/13) | | 59/1790046 |
skin (4/7) | | 4/63709 |
stomach (3/3) | | 15/464400 |
uncharacterized tissue (20/22) | | 83/2608732 |
vascular (3/3) | | 31/1057077 |
|
|
SNP | rs2057481 (C/T:mrna-utr);  rs2165601 (A/G:locus-region);  rs1254677 (C/T:locus-region);  rs1015447 (C/T:intron);  rs1802821 (A/G:coding-nonsyn);  rs2255627 (A/G:locus-region);  rs962962 (A/G:intron);  rs2028519 (A/G:locus-region);  rs1661436 (G/C:locus-region);  rs2352539 (A/T:intron);  rs2284999 (C/T:locus-region);  rs2761143 (T/C:locus-region);  rs1967773 (C/T:intron);  rs2301104 (A/G:locus-region);  rs1040995 (A/G:intron);  rs1957754 (C/T:intron);  rs1319462 (A/G:locus-region);  rs2882968 (C/T:locus-region);  rs2181600 (T/G:intron);  rs3062103 (AAAC/-:intron);  rs1152572 (G/A:locus-region);  rs1555584 (C/T:intron);  rs966824 (C/T:intron);  rs2274012 (A/G:locus-region);  rs994740 (C/T:locus-region);  rs1951795 (A/C:intron);  rs984788 (C/T:locus-region);   |
Evidence | Amplification in Prostate cancer
|